Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
for Myelodysplastic Syndromes
7 locations incl. Jacksonville
Sponsor: Syntrix Biosystems, Inc.
Sex: All·Age: 18+
Code: NCT04245397·Phase 1·Recruiting